Care at Mayo Clinic for children with ADHD

Each year, more than 2,000 children and teenagers with ADHD are treated by experts at Mayo Clinic's campus in Minnesota.

Team approach tailored to your child's needs

Mayo Clinic's campus in Minnesota offers a pediatric clinic for children ages 3 to 18 who have ADHD. This multispecialty team provides a comprehensive diagnostic evaluation — including a new or second opinion — and a comprehensive treatment plan.

Mayo's Child and Adolescent ADHD Clinic offers a variety of services, including:

  • Comprehensive evaluation
  • Medication management
  • Behavioral management strategies for parents
  • Advanced skills in parent-child interaction
  • Social skills training for children
  • Behavioral control strategies for children and teenagers
  • Individual and group therapies for ADHD

Depending on your child's needs, your care team may include specialists in other areas who work together to evaluate and treat your child.

If you live outside the area, when your child leaves Mayo Clinic, your team members can consult with your hometown doctor to adjust the treatment plan as needed.

March 11, 2016
References
  1. Attention-deficit/hyperactivity disorder. In: Diagnostic and Statistical Manual of Mental Disorders DSM-5. 5th ed. Arlington, Va.: American Psychiatric Association; 2013. http://www.psychiatryonline.org. Accessed Jan. 5, 2016.
  2. Attention deficit hyperactivity disorder (ADHD). National Institute of Mental Health. http://www.nimh.nih.gov/health/topics/attention-deficit-hyperactivity-disorder-adhd/index.shtml. Accessed Dec. 9, 2015.
  3. Rostain A, et al. Toward quality care in ADHD: Defining the goals of treatment. Journal of Attention Disorders. 2015;19:99.
  4. Vande Voort JL, et al. Impact of the DSM-5 attention-deficit/hyperactivity disorder age-of-onset criterion in the US adolescent population. Journal of the American Academy of Child and Adolescent Psychiatry. 2014;53:736.
  5. Cook AJ. Allscripts EPSi. Mayo Clinic, Rochester, Minn. Nov. 18, 2015.
  6. Rowland AS, et al. The prevalence of ADHD in a population-based sample. Journal of Attention Disorders. 2015;19:741.
  7. Attention-deficit/hyperactivity disorder (ADHD). Centers for Disease Control and Prevention. http://www.cdc.gov/ncbddd/adhd/. Accessed Jan. 5, 2016.
  8. For parents and caregivers. National Resource Center on ADHD. http://www.chadd.org/Understanding-ADHD/For-parents-caregivers.aspx. Accessed Jan. 5, 2016.
  9. Attention-deficit hyperactivity disorder (ADHD). American Academy of Family Physicians. http://familydoctor.org/familydoctor/en/diseases-conditions/attention-deficit-hyperactivity-disorder-adhd.html. Accessed Jan. 5, 2016.
  10. Harris MN, et al. ADHD and learning disabilities in former late preterm infants: A population-based birth cohort. Pediatrics. 2013;132:e630.
  11. ADHD. National Alliance on Mental Illness. https://www.nami.org/Learn-More/Mental-Health-Conditions/ADHD/Overview. Accessed Jan. 5, 2016.
  12. Bader A, et al. Complementary and alternative therapies for children and adolescents with ADHD. Current Opinion in Pediatrics. 2012;24:760.
  13. Southammakosane C, et al. Pediatric psychopharmacology for treatment of ADHD, depression, and anxiety. Pediatrics. 2015;136:351.
  14. Connolly JJ, et al. Attention-deficit hyperactivity disorder and pharmacotherapy — Past, present, and future: A review of the changing landscape of drug therapy. Therapeutic Innovation and Regulatory Science. 2015;49:632.
  15. Levy S, et al. Childhood ADHD and risk for substance dependence in adulthood: A longitudinal, population-based study. PLOS One. 2014;9:e105640.
  16. Bhagia J (expert opinion). Mayo Clinic, Rochester, Minn. Feb. 21, 2016.